Kilitch Drugs (India) (KILITCH.NS) Earnings Analysis

Kilitch Drugs (India) (KILITCH.NS) has no confirmed upcoming earnings date. Trailing P/E 19.88.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KILITCH.NS next report earnings?

No confirmed upcoming earnings date is currently scheduled for KILITCH.NS. This page updates as the calendar is published.

KILITCH.NS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-184.24 INRn/an/an/a
2026-02-091.27 INRn/an/an/a
2025-11-102.48 INRn/an/an/a
2025-08-110.92 INRn/an/an/a
2025-05-193.23 INRn/an/an/a

KILITCH.NS valuation and analyst view

Trailing P/E19.88
Trailing EPS8.81 INR
Price / book2.17
Dividend yield0.00%
Market cap6.23B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Kilitch Drugs (India) (KILITCH.NS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for KILITCH.NS. This page updates as the calendar is published.

Did KILITCH.NS beat earnings last quarter?

Consensus estimate data was not available for KILITCH.NS's 2026-05-18 report.

What is KILITCH.NS's current P/E ratio and EPS?

KILITCH.NS trades at a trailing P/E of 19.88 on trailing EPS of 8.809736580807195 INR.

What do analysts rate KILITCH.NS?

KILITCH.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.